Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride treatment of nephrotic edema
2015-001946-26Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amiloride in Idiopathic nephrotic syndrome (INS), sponsored by Aarhus University Hospital. Primary endpoints: Change in body weight and Urinary sodium concentration. Started Oct 2015; status: terminated.
02
Drugs
amiloride
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on 2015-001946-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001946-26.